Reply to Sorooshian and Snow, "Is Alternate-Day Therapeutic Drug Monitoring in the Intensive Care Unit Not Intensive Enough?"

Antimicrob Agents Chemother. 2018 Sep 24;62(10):e01343-18. doi: 10.1128/AAC.01343-18. Print 2018 Oct.

A Fournier^{1

2}, P Eggimann³, O Pantet³, J L Pagani³, E Dupuis-Lozeron⁴, A Pannatier¹, F Sadeghipour^{1

2}, P Voirol^{1

2}, Y-A Que⁵

¹ Service of Pharmacy, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
² School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland.
³ Service of Intensive Care Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
⁴ Unit of Population Epidemiology, Department of Community Medicine, Primary Care and Emergency Medicine, Geneva University Hospitals, Geneva, Switzerland.
⁵ Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland yok-ai.que@insel.ch.

No abstract available

Publication types